Header Logo

Connection

ANDREW BADACHHAPE to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications ANDREW BADACHHAPE has written about Xenograft Model Antitumor Assays.
ANDREW BADACHHAPE
Connection Strength
0.079
Xenograft Model Antitumor Assays
  1. Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
    View in: PubMed
    Score: 0.046
  2. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.